118 related articles for article (PubMed ID: 20470194)
1. Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse.
Thomas DM; Fox J; Haston CK
Int J Radiat Biol; 2010 Jun; 86(6):436-44. PubMed ID: 20470194
[TBL] [Abstract][Full Text] [Related]
2. A selenocysteine derivative therapy affects radiation-induced pneumonitis in the mouse.
Kunwar A; Jain VK; Priyadarsini KI; Haston CK
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):654-61. PubMed ID: 23721109
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of radiation-induced skin fibrosis with imatinib.
Horton JA; Chung EJ; Hudak KE; Sowers A; Thetford A; White AO; Mitchell JB; Citrin DE
Int J Radiat Biol; 2013 Mar; 89(3):162-70. PubMed ID: 23083077
[TBL] [Abstract][Full Text] [Related]
4. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice].
Li L; Li YQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279
[TBL] [Abstract][Full Text] [Related]
5. Combined CXCR1/CXCR2 antagonism decreases radiation-induced alveolitis in the mouse.
Fox J; Gordon JR; Haston CK
Radiat Res; 2011 May; 175(5):657-64. PubMed ID: 21342009
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec).
Samoszuk M; Corwin MA
Int J Cancer; 2003 Sep; 106(5):647-52. PubMed ID: 12866022
[TBL] [Abstract][Full Text] [Related]
7. Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model.
Li M; Abdollahi A; Gröne HJ; Lipson KE; Belka C; Huber PE
Radiat Oncol; 2009 Dec; 4():66. PubMed ID: 20025728
[TBL] [Abstract][Full Text] [Related]
8. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced lung response of AcB/BcA recombinant congenic mice.
Lemay AM; Haston CK
Radiat Res; 2008 Sep; 170(3):299-306. PubMed ID: 18763862
[TBL] [Abstract][Full Text] [Related]
10. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.
Chhina MK; Nargues W; Grant GM; Nathan SD
Future Cardiol; 2010 Jan; 6(1):19-35. PubMed ID: 20014985
[TBL] [Abstract][Full Text] [Related]
12. CXC receptor 1 and 2 and neutrophil elastase inhibitors alter radiation-induced lung disease in the mouse.
Fox J; Haston CK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):215-22. PubMed ID: 22929857
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
Daniels CE; Wilkes MC; Edens M; Kottom TJ; Murphy SJ; Limper AH; Leof EB
J Clin Invest; 2004 Nov; 114(9):1308-16. PubMed ID: 15520863
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
Klion AD; Noel P; Akin C; Law MA; Gilliland DG; Cools J; Metcalfe DD; Nutman TB
Blood; 2003 Jun; 101(12):4660-6. PubMed ID: 12676775
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab.
Sternlicht MD; Wirkner U; Bickelhaupt S; Lopez Perez R; Tietz A; Lipson KE; Seeley TW; Huber PE
Respir Res; 2018 Jan; 19(1):14. PubMed ID: 29347981
[TBL] [Abstract][Full Text] [Related]
16. Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice.
Paun A; Fox J; Balloy V; Chignard M; Qureshi ST; Haston CK
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1198-205. PubMed ID: 20610040
[TBL] [Abstract][Full Text] [Related]
17. Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia.
Chang YT; Ringman Uggla A; Osterholm C; Tran PK; Eklöf AC; Lengquist M; Hedin U; Tran-Lundmark K; Frenckner B
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1159-66. PubMed ID: 22447953
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
19. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
[TBL] [Abstract][Full Text] [Related]
20. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH
Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
